Vaccine-induced protection is substantial to control, prevent, and reduce the spread of infectious diseases and to get rid of infectious diseases. In this paper, we propose an SVEIR epidemic model with age-dependent vaccination, latency, and infection. The model also considers that the waning vaccine-induced immunity depends on vaccination age and the vaccinated individuals fall back to the susceptible class after losing immunity. The model is a coupled system of (hyperbolic) partial differential equations with ordinary differential equations. The global dynamics of the model is established through construction of appropriate Lyapunov functionals and application of Lasalle's invariance principle. As a result, the global stability of the infection-free equilibrium and endemic equilibrium is obtained and is fully determined by the basic reproduction number R 0 .
Introduction
Protection induced by vaccines plays a significant role in preventing and reducing the transmission of infectious diseases. One of the greatest successful events of vaccination is illustrated through the eradication of small-pox. It is reported in [1] that the case of small-pox was last recorded in 1977. Immunity conveyed by vaccination depends on different vaccines and vaccination policies-lifelong immunity occurs for certain vaccines while immunization period is induced by some vaccines. However, waning vaccineinduced immunity takes place (naturally) after immunization process. It is reported in [2] that a significant decay in the proportion of chicken pox took place in US in 1995 after conducting a universal vaccination campaign. But, surprisingly new cases of chicken pox appeared mainly in highly vaccinated school communities in US. Some studies were conducted and revealed waning vaccine-induced immunity in children under protection induced by vaccine.
Moreover, this was also investigated in [3] [4] [5] and it was proved that such waning of immunity is attached to the time since vaccination and the age at vaccination. In this regard, it was published in [6, 7] that the time of vaccineinduced immunity depends on individuals features and vaccine age.
From the abovementioned statements and citations, we see that it is necessary to associate waning vaccine-induced immunity with vaccination in infectious disease models and it is interesting to investigate the impact of waning vaccineinduced immunity on the dynamics of infectious diseases. Many mathematical models on vaccination have been already investigated and, to cite a few of them, see [2, [8] [9] [10] [11] [12] [13] [14] [15] [16] . Some of the above-cited model considered either age-dependent vaccination, while some did not.
Despite vaccination age-structure being the main and appropriate feature required in the dynamics of infectious diseases with waning induced-vaccine immunity, most of epidemiological models with vaccination including waning 2 Abstract and Applied Analysis induced-vaccine immunity were studied after assuming a constant rate of immunity loss (to name a few, see [9, 10, 15] ). Age-dependent vaccination was considered in some epidemiological models studied recently in [1, 2, [17] [18] [19] [20] . However, some of these works considered either waning vaccine-induced immunity or not, either vaccine-agedependent waning vaccine-induced immunity or not, either age-dependent latency or not, either age-dependent relapse or not, and either age-dependent infection or not. In [17] an SVIR epidemic model with continuous age-dependent vaccination was formulated to establish the global stability of equilibria. In [18] an SVIJS epidemic model with agedependent vaccination was considered to study the asymptotical behavior of the equilibria, after assuming that agedependent vaccine-induced immunity decays with time after vaccination. In [19] an SVIS epidemic model with agedependent vaccination and vaccine-age-dependent waning vaccine-induced immunity and treatment was formulated to investigate backward bifurcations. In [2] an SVIR epidemic model with vaccination age was considered to establish global stability of equilibria, after assuming that vaccine-induced immunity decays with time after vaccination. In [20] an SVEIR epidemic model with age-dependence vaccination, latency, and relapse was formulated to establish the global stability of the equilibria. In [1] a multigroup SVEIR epidemic model with latent class and vaccination age was formulated to study global stability of equilibria, after assuming that vaccine-induced immunity decays with time after vaccination and likewise in [17] [18] [19] .
Recently, in [14] an SVEIR epidemic model with continuous age-structure in the latent and infectious classes and without continuous age-structure in the vaccinated class was formulated to prove the global stability of equilibria, while in [20] an SVEIR epidemic model with continuous age-structure in the latent, infectious, and recovered classes and with vaccine-age-dependent waning vaccine-induced immunity was formulated. Moreover, in [14] the latency and infection ages are denoted by the same variable . Similarly, in [20] the latency, relapse, and vaccination ages are denoted by the same variable . In spite of this, to the best of our knowledge, the global dynamics of an SVEIR epidemic model with continuous age-structure in latency, infection, vaccination, and vaccine-age-dependence waning vaccineinduced immunity has not yet been neither considered nor investigated using the approach of Lyapunov functionals. The aim of this work is to fill this gap by investigating the global dynamics of an SVEIR epidemic model as above defined. Motivated by [14, 20] , we propose a new SVEIR epidemic model originated from an existing SVEIR formulated in [1] , by considering continuous age-structure in latency and infection in addition to age-dependence vaccination and vaccine-age-dependence waning vaccine-induced immunity (which the authors took into account in [1] ). However, the latency, infection, and vaccination ages are all denoted by , as in [14, 20] . Moreover, in this paper, we also consider a more significant incidence rate (taking into account transmission by both age-mates infective individuals and infective individuals of any age) of the form
where 0 ( ) and ( , ) are defined below, instead of the classical incidence rate of the form
where ( ) denotes the coefficient of disease transmission from infective individual, with infection age , to susceptible individual. The latter is considered in the references therein where continuous age-structure in infection is taken into account.
The model splits the total population into five epidemiological compartments, namely, the susceptible compartment, the vaccinated compartment, the latent compartment, infected compartment, and the removed compartment. Let ( ) and ( ) be the number of individuals in the susceptible and removed compartments at time , respectively. Let V( , ), ( , ), and ( , ) be the density of vaccinated, (latently) infected, and (actively) infected individuals with vaccination, latency, and infection age at time , respectively. It follows that ( ), ( ), and ( ) defined by
are the number of individuals in the vaccinated, latent, and infected compartments, respectively.
The model to be investigated consists of a hybrid system of nonlinear coupled ordinary differential equations and partial differential equations of the form
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And initial conditions
where 0 and 0 are initial size of susceptible and removed individuals, respectively, and V 0 ( ), 0 ( ), and 0 ( ) are initial age-density of vaccinated, latent, and infective individuals, respectively. Moreover, V 0 , 0 , and 0 are Lebesgue integrable functions, and it is assumed that the recruitment of newly vaccinated individuals in the vaccinated compartment is done at age zero. The meaning of parameters in (4)-(5) is given below:
Λ: constant recruitment rate of susceptible individuals ]: rate of vaccination of susceptible individuals 0 : natural mortality rate of individuals ( ): age-specific rate of waning vaccine-induced immunity ( ): age-specific natural mortality rate ( ): age-specific removal rate ( ): age-specific rate moving from latent to infective 0 ( ): age-specific infection rate of susceptible individuals by infective individuals (of the same age-intracohort contagion) ( , ): probability that an infective individual of age will successfully infect a susceptible individual of age , after contact
In the sequel, we make following assumptions on parameters in (4)- (5):
with essential upper bounds , , , , , , 0 and ( , ⋅), respectively. 
This paper is composed sections, in addition to the introduction, which are structured as follows. In Section 2, we present some preliminary result on compactness property of the semiflow generated by (4)- (5) and we discuss its asymptotic smoothness property. The uniform persistence property of (4)- (5) is addressed in Section 4. Section 3 deals with the existence of equilibria and the formulation of the threshold parameter R 0 (the basic reproduction number). Local stability of equilibria for (4) is established in Section 5, while global stability of equilibria for (4) is examined in Section 6.
Preliminaries
We consider the Banach space
endowed with the norm
where ‖ ⋅ ‖ 1 = ‖ ⋅ ‖ L 1 , for any ( , , , , ) ∈ X. Let us denote by X + the positive cone of the Banach space X such that
system (4) is well-posed, under assumption A1, due to [21] . Thus, a continuous semiflow Φ : R + × X + → X + is obtained and it is defined by (4) such that
4 Abstract and Applied Analysis Now, we introduce the functions
By integrating the second, third, and fourth equations of (4) along the characteristic line − = constant, respectively, we get
where
Taking the norm of Φ (X 0 ) and using the positiveness of the components of Φ (X 0 ), we get
Differentiating (15) with respect to leads to
Next, we seek for the estimates of each time-derivative on the right hand side (16) . First, we have
Applying the Leibniz Integral Rule to the first integral in (17) yields
Likewise, we also have
and
Therefore, we get
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that is,
Thus, we obtain
If we consider the state space Γ of (4), defined by
we get
for any ≥ 0, whenever X 0 ∈ Γ. Moreover lim sup
for any X 0 ∈ X + . Then, we state the following result.
Lemma 1. The set Γ is positively invariant for Φ; that is,
Moreover, Φ (X 0 ) is point dissipative and the set Γ attracts all points in X + .
As we aim to make use of the Lasalle's Invariance Principle, we are required to establish the relative compactness of the orbit {Φ (X 0 ) : ≥ 0} in X + due to the infinite dimensional Banach space X. For this, we consider two operators Θ and Ψ, (Θ, Ψ :
Thus, Φ (X 0 ) = Θ (X 0 ) + Ψ (X 0 ), for any ≥ 0; and from the proof of [22, Proposition 3.13] and Lemma 1, we get to the following result.
Theorem 2. For X 0 ∈ Γ, the orbit {Φ (X 0 ) : ≥ 0} has a compact closure in X + if the following conditions are satisfied:
for any > 0, lim →∞ Δ( , ) = 0, and if X 0 ∈ Γ with
(ii) For any ≥ 0, Ψ (⋅) maps any bounded sets of Γ into a set with compact closure in X + .
For verifying conditions (i) and (ii) of Theorem 2, we need lemmas.
Proof. Clearly, we see that lim →∞ Δ( , ) = 0. Making use of some equations in (13), we get
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Taking the initial condition X 0 ∈ Γ such that ‖X 0 ‖ X ≤ and ≥ 0, we have 
, )
= 0 uniformly with respect to X 0 ∈ Γ, wherẽ∈ {Ṽ,̃,̃}. It follows from (13) and (30) that
and hence, using Lemma 1, we get
and hence, (i), (ii), and (iv) follow. To establish (iii), we take a sufficiently small ℎ such that ℎ ∈ (0, ) and we show that
Indeed, ( ) is a nondecreasing function of such that 0 ≤ ( ) ≤ 1 satisfying
On the other hand, the Lipschitz continuity of (⋅) is obtained from the first equation of (4), using the boundedness of the solution of (4) (see Lemma 1) ; that is, there exists > 0 such that
Since ](2Λ + )ℎ/̃does not depend on the initial data X 0 ∈ Γ and ](2Λ + )ℎ/̃→ 0 as ℎ → 0 + , it follows from (35) that (iii) is satisfied.
Therefore, From Lemma 1 and Theorem 2, the existence result of global attractors (see [24] ) follows.
≥ 0} has a global attractor in X + , which attracts any bounded subset of X + .
Equilibria and Basic Reproduction Number
System (4) has a unique disease-free equilibrium
Apart from 0 , system (4) could also have an endemic equilibrium. We suppose that there exists an endemic equilibrium for system (4) denoted by
are satisfied. In addition, * also satisfies (5), i.e.,
The second equation of (38) and the first equation of (39) give
It follows from the third equation of (38) that
Equations (5) and (41) together with the fourth equation of (38) yield
We introduce parameters R 0 , , , and such that
By substituting (42) into the second equation of (39), we have
And hence,
Then, substituting (37), (40), (42), and (44) into the first equation of (38) yields 
A threshold condition is derived from the existence condition for the endemic equilibrium * such that R 0 > 1. Thus, the parameter R 0 , given by the first equation of (43), can be called the basic reproduction number of system (4). Moreover, R 0 can also be expressed as
R intra and R inter can be understood, respectively, as the basic reproduction numbers for the corresponding model with purely intracohort infection mechanism (i.e., situation in which individuals can only be infected by their age-mates) and for the corresponding model with purely intercohort infection mechanism (i.e., situation in which individuals can be infected by those of any age).
Therefore, we state the following. 
Uniform Persistence
This section is devoted to the uniform persistence of system (4) under the condition R 0 > 1. For this, we introduce a function :
where ( , , , , ) ∈ X + . Furthermore, we consider the set X 0 defined by
such that Φ (X 0 ) → 0 as → ∞ whenever X 0 ∈ X + \ X 0 . 
for X 0 ∈ X + . (4) is uniformly weakly -persistent.
Proof. We assume that, for any * > 0, we can find X * 0 ∈ X + such that lim sup
Since R 0 > 1, then we can find a small enough * 0 > 0 such that
In particular, we can find X * 0 /2 0
We can assume that, for any ≥ 0, (Φ (X * 0 /2 0 )) ≤ * 0 . It follows from the first equation of (4) that
We apply the Laplace transform L to the above inequality and we obtain
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It follows that
This yields lim sup →∞ ( ) ≥ (Λ − 0 )/(] + 0 ). We can assume that, for any ≥ 0,
Now, we consider the boundary condition defined by the second equation of (5) and we get
We apply the Laplace Transform L to the above inequality so that
Dividing the above inequality by L{ (0, )} yields
First, taking the limit inferior as → ∞ on both sides of the above inequality, we obtain
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Next, take the limit as → 0 on both sides of the above inequality, we get
which contradicts the inequality given in (54).
Combining the results from Theorems 5 and 8 with [25, Theorem 3.2] leads to the uniform (strong) -persistence as follows. (11), is a function X : R → X + such that Φ (X( )) = X( + ) for any ( , ) ∈ R + × R.
Note that a global attractor will only contain points with total trajectories through them as it needs to be invariant. So, the -limit point of a total trajectory X, passing through X(0) = X 0 , is given by
A total trajectory X( ) = ( ( ), V(⋅, ), (⋅, ), (⋅, ), ( )) satisfies 
Proof. We consider the boundary condition given by the second equation of (5). Using (25) and (ii) of A1, we get
From the first equation of (4), we have
This yields
Taking the limit inferior as → ∞ in (72) leads to lim inf
Therefore, ( ) ≥ 1 . It follows that V(0, ) ≥ 1 ] š 2 . Now, we consider again the boundary condition given by the second equation of (5). It is easy to see that
It follows from Theorem 9 and Definition 7 that (0, ) ≥ * š 3 . Further, considering the boundary condition given by the third equation of (5), we obtain
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Taking the limit inferior as → ∞ in (78), we obtain lim inf
And therefore ( ) ≥ 5 . By choosing such that = min { }, for ∈ {1, 2, 3, 4, 5}, we get
Local Stability of Equilibria
The conditions of stability for each equilibrium will be derived through linearization technique around the equilibrium. The conditions of stability for the disease-free equilibrium 0 can be investigated through the following result.
Theorem 12. If
Proof. To investigate the stability of the disease-free equilibrium 0 , we denote bỹ( ),Ṽ( , ),̃( , ),̃( , ), and ( ) the perturbations of ( ), V( , ), ( , ), ( , ), and ( ), respectively, such that
The perturbations satisfy the following:
after substituting (81) into (4) and neglecting the terms of order higher or equal to two, with boundary conditions
after substituting (81) into (5) and neglecting the terms of order higher or equal to two. Now, we consider the exponential solutions of systems (82)-(83) 
where , V( ), ( ), ( ), and (real or complex number) satisfy the following system:
with boundary conditions
From the second, third, and fourth equations of (85), we get
respectively, where V(0), (0), and (0) are given by (86). Substituting the last equation of (87) into the boundary condition given by the second equation of (86) yields the characteristic equation
where Proof. Likewise for the disease-free equilibrium, we perturb the disease-endemic equilibrium by letting
Substituting ( ) =̃( ) + * , V( , ) =Ṽ( , ) + V * ( ), ( , ) = ( , ) + * ( ), and ( , ) =̃( , ) + * ( ), ( ) =̃( ) + * into (4) and neglecting the terms of second order and above, the perturbations satisfy the linear system
with boundary conditions 
where , V( ), ( ), ( ), and (real or complex number) satisfy the system
Similarly to the process leading to the characteristic equation (88), the characteristic equation at the disease-endemic equilibrium * is given by
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It is sufficient to prove that (96) has no root with nonnegative real part. So, we suppose that (96) has a complex root with nonnegative real part denoted by
where ≥ 0 and ̸ = 0. It follows from (96) that
and hence
Since RC * ( + ) ≤ C * ( ) is always true and
Therefore, the latter statement contradicts (102).
Global Stability of Equilibria
To investigate the global asymptotic stability of equilibria of system (4) we shall use suitable Volterra-type Lyapunov functions of the form
We state the following results.
Theorem 14.
The disease-free equilibrium 0 of (4) is globally asymptotically stable if R 0 ≤ 1.
Proof. A Lyapunov function
0 of the form
is considered, where
The functions and are nonnegative functions to be chosen suitably and carefully.̇0, = 1, . . . , 5, denote the derivatives Abstract and Applied Analysis 15 of 0 with respect to along the solution to (4) and are given bẏ0
Therefore,
i.e.,̇0
after choosing and such that
Note that
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Using assumption A2, we show that
By assumption A3, obtain
Next, we choose functions and such that
It follows from (117) and (118) that (0) = R 0 and
Moreover, by differentiation of (117) and (118) with respect to age , we obtain
respectively. Therefore, (113) is reduced tȯ
We denote
Since
it is easy to check that ( ) has two negative (real) roots. Moreover, ( ) > 0 for every ≥ 0. Therefore, the sign oḟ 0 (⋅) will be determined by the sign of
Thus, three cases occur:
Case 2 ( ( ) = 2 0 ). For this value of ( ), we have
It results from the above that the derivative of 0 ( ) along the solutions of (4) 
with ( ) = − 1 − ln , for any > 0.
Thus, we havė *
Using (37), (44), and (45) together with the first equation of (38), we obtaiṅ *
We add and subtract, carefully, some terms to the above expression, and we also identify group of terms in the form given by ( ) = − 1 − ln . We obtaiṅ *
By differentiating * 2 with respect to , we obtaiṅ *
Using the second equation of (38) after integrating by part, we geṫ *
Moreover,
Similarly to * 2 , from * 3 and * 4 we get, respectively, *
anḋ *
while using the fifth equation of (38) * 5 leads tȯ *
By combining (130), (136), (137), (138), and (139), we obtaiṅ
This yieldṡ Therefore, we obtaiṅ * ( ) < 0, From (144), we say that the derivative of * ( ) along the solutions of (4) iṡ * ( ) < 0. If ( ) = * , V( , ) = V * ( ), ( , ) = * ( ), ( , ) = * ( ), and ( ) = * are simultaneously satisfied, then we obtaiṅ * ( ) = 0 from (76). Moreover, it can be verified that {( , V, , , ) :̇ * ( ) = 0} = { * }. Therefore, it results from Lasalle's Invariance Theorem [26, p. 200 ] that * is globally asymptotically stable, if R 0 > 1.
The results from Theorems 14 and 15 show that there exists a threshold parameter, called the basic reproduction number and denoted by R 0 , that is essential in the stability analysis of the global dynamics of the model defined by system (4) . Moreover, such a parameter can play a crucial role in the implementation of human vaccination policies. As we can see in 
the rise in rate of vaccination of (infant) susceptible individuals against an SEIR infection can reduce the spread of the infection and help to elaborate control measures to prevent and reduce the spread of the infection.
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